XML 17 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 352.6 $ 187.1
Debt securities available-for-sale, at fair value (amortized cost $520.2 million at March 31, 2021 and $612.4 million at December 31, 2020) 521.1 613.9
Accounts receivable 147.8 157.1
Inventories 30.1 28.0
Other current assets 33.8 30.1
Total current assets 1,085.4 1,016.2
Deferred tax assets 325.6 319.4
Debt securities available-for-sale, at fair value (amortized cost $249.6 million at March 31, 2021 and $226.7 million at December 31, 2020) 249.6 227.1
Right-of-use assets 97.0 82.8
Equity securities 38.9 38.2
Property and equipment, net 45.3 44.6
Restricted cash 3.2 3.2
Other long-term assets 1.4 3.2
Total assets 1,846.4 1,734.7
Current liabilities:    
Accounts payable and accrued liabilities 171.9 168.7
Other current liabilities 18.1 17.8
Total current liabilities 190.0 186.5
Convertible senior notes 322.0 317.9
Operating lease liabilities 107.5 94.4
Other long-term liabilities 21.3 9.7
Total liabilities 640.8 608.5
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding at March 31, 2021 and December 31, 2020 0.0 0.0
Common stock, $0.001 par value; 220.0 shares authorized; issued and outstanding shares were 94.5 at March 31, 2021 and 93.5 at December 31, 2020 0.1 0.1
Additional paid-in capital 1,897.8 1,849.7
Accumulated other comprehensive income 1.0 1.8
Accumulated deficit (693.3) (725.4)
Total stockholders’ equity 1,205.6 1,126.2
Total liabilities and stockholders’ equity $ 1,846.4 $ 1,734.7